Get the latest Science News and Discoveries
mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis
Reactive astrocytes emerge as a primary consequence of TSC2 loss in tuberous sclerosis complex, implicating glial dysfunction as a primary driver of pathogenesis and highlighting the astrocytes as potential therapeutic targets for tuberous sclerosis complex-related neuropathology.
None
Or read this on Nature
